![Marlene Wright Barton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marlene Wright Barton
President chez
Wright Regulatory Consulting LLC
Profil
Marlene Wright Barton is currently working as an Operating Advisor at Revival Healthcare Capital LLC.
She is also the Chief Regulatory & Compliance Officer at Syncromune, Inc. and the President of Wright Regulatory Consulting LLC and WRC LLC.
Previously, she worked as a Senior Advisor at PTV Sciences LP and as the EVP, Chief Regulatory and Compliance Officer at ImmunSYS, Inc. Ms. Barton has a graduate degree from SUNY Empire State College and an undergraduate degree from the State University of New York at Binghamton.
Postes actifs de Marlene Wright Barton
| Sociétés | Poste | Début |
|---|---|---|
Revival Healthcare Capital LLC
 Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Consultant / Advisor | - |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops intratumoral immunotherapy platform for treating metastatic solid tumors | Compliance Officer | 01/12/2021 |
Wright Regulatory Consulting LLC | President | 01/09/2020 |
WRC LLC | President | 01/01/2010 |
Anciens postes connus de Marlene Wright Barton
| Sociétés | Poste | Fin |
|---|---|---|
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Compliance Officer | 01/09/2020 |
PTV Sciences LP
 PTV Sciences LP Investment ManagersFinance PTV Healthcare Capital seeks invests in companies located in the United States. The firm focuses on companies operating in the fields of medical devices, healthcare services, and healthcare technology sectors. It provides financing for early and later stage capital requirements. | Private Equity Investor | - |
Formation de Marlene Wright Barton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
SUNY Empire State College
 SUNY Empire State College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Healthcare Capital seeks invests in companies located in the United States. The firm focuses on companies operating in the fields of medical devices, healthcare services, and healthcare technology sectors. It provides financing for early and later stage capital requirements. | Finance |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Health Technology |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Finance |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops intratumoral immunotherapy platform for treating metastatic solid tumors | Health Technology |
Wright Regulatory Consulting LLC | |
WRC LLC |
